NASONEX NASAL SPRAY

Krajina: Izrael

Jazyk: angličtina

Zdroj: Ministry of Health

Aktívna zložka:

MOMETASONE FUROATE 50 MCG/DOSE

Dostupné z:

MERCK SHARP & DOHME ISRAEL LTD

ATC kód:

D07AC13

Forma lieku:

SOLUTION

Spôsob podávania:

NASAL

Výrobca:

SCHERING-PLOUGH LAB.NV BELGIUM

Terapeutické skupiny:

MOMETASONE

Terapeutické indikácie:

In adults and children 3 years of age and older to treat the symptoms of seasonal or perennial rhinitis. In patients 12 years old and above who have a history of moderate to severe symptoms of seasonal allergic rhinitis prophylactic treatment with Nasonex Aqueous Nasal Spary is recommended 2- 4 weeks prior to the anticipated start of the pollen season.

Dátum Autorizácia:

2013-03-01